Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges

被引:215
作者
Kibria, Golam [1 ]
Ramos, Erika K. [1 ]
Wan, Yong [1 ,2 ,3 ]
Gius, David R. [1 ,4 ]
Liu, Huiping [1 ,3 ,5 ]
机构
[1] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Div Reprod Sci Med, Chicago, IL 60611 USA
[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Northwestern Univ, Dept Radiat Oncol, Feinberg Sch Med, Chicago, IL 60611 USA
[5] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA
关键词
exosomes; drug delivery system; biodistribution; tumor homing; CELL-DERIVED EXOSOMES; DENDRITIC CELLS; EXTRACELLULAR VESICLES; MEDIATED ENDOCYTOSIS; MESSENGER-RNAS; TUMOR-GROWTH; IN-VITRO; PROTEINS; BIODISTRIBUTION; TRACKING;
D O I
10.1021/acs.molpharmaceut.8b00277
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Exosomes play a pivotal role in mediating intercellular communications and package delivery. They have recently been discovered to serve as diagnostic biomarkers as well as a possible drug delivery vehicle based on their nanometer size range and capability to transfer biological materials to recipient cells. Their unique biocompatibility, high stability, preferred tumor homing, and adjustable targeting efficiency can make exosomes an attractive and potentially effective tool of drug delivery in cancer therapy. While exosomes possess properties that make them uniquely suitable for delivery of bioactive molecules, there remains a to-be-filled gap between the current understanding about exosome biology and the ideal application scenarios. In this review, we summarize the characteristics enabling the potential of exosomes for drug delivery as well as the outstanding questions related to exosome composition and function, production and purification, bioengineering and targeting, uptake and biodistribution, efficacy and immune regulation, etc. Advanced technologies are demanded to visualize, characterize, and sort heterogeneous exosome populations. We are positive that the deeper and more comprehensive understanding of exosome biology as well as advanced nanotechnology will certainly accelerate its therapeutic applications.
引用
收藏
页码:3625 / 3633
页数:9
相关论文
共 104 条
[1]
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].
Alvarez-Erviti, Lydia ;
Seow, Yiqi ;
Yin, HaiFang ;
Betts, Corinne ;
Lakhal, Samira ;
Wood, Matthew J. A. .
NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179
[2]
[Anonymous], 1996, AIDS Treat News, P3
[3]
Biodistribution and function of extracellular miRNA-155 in mice [J].
Bala, Shashi ;
Csak, Timea ;
Momen-Heravi, Fatemeh ;
Lippai, Dora ;
Kodys, Karen ;
Catalano, Donna ;
Satishchandran, Abhishek ;
Ambros, Victor ;
Szabo, Gyongyi .
SCIENTIFIC REPORTS, 2015, 5
[4]
Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[5]
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC [J].
Besse, Benjamin ;
Charrier, Melinda ;
Lapierre, Valerie ;
Dansin, Eric ;
Lantz, Olivier ;
Planchard, David ;
Le Chevalier, Thierry ;
Livartoski, Alain ;
Barlesik, Fabrice ;
Laplanche, Agnes ;
Ploix, Stephanie ;
Vimond, Nadege ;
Peguillet, Isabelle ;
Thery, Clotilde ;
Lacroix, Ludovic ;
Zoernig, Inka ;
Dhodapkar, Kavita ;
Dhodapkar, Madhav ;
Viaud, Sophie ;
Soria, Jean-Charles ;
Reiners, Katrin S. ;
von Strandmann, Elke Pogge ;
Vely, Frederic ;
Rusakiewicz, Sylvie ;
Eggermont, Alexander ;
Pitt, Jonathan M. ;
Zitvogel, Laurence ;
Chaput, Nathalie .
ONCOIMMUNOLOGY, 2016, 5 (04)
[6]
Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma [J].
Bu, Ning ;
Wu, Haiqin ;
Sun, Bingzhong ;
Zhang, Guilian ;
Zhan, Shuqin ;
Zhang, Ru ;
Zhou, Le .
JOURNAL OF NEURO-ONCOLOGY, 2011, 104 (03) :659-667
[7]
Exosome-based immunotherapy [J].
Chaput, N ;
Taïeb, J ;
Schartz, NEC ;
André, F ;
Angevin, E ;
Zitvogel, L .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) :234-239
[8]
Exosomes as potent cell-free peptide-based vaccine.: II.: Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection [J].
Chaput, N ;
Schartz, NEC ;
André, F ;
Taïeb, J ;
Novault, S ;
Bonnaventure, P ;
Aubert, N ;
Bernard, J ;
Lemonnier, F ;
Merad, M ;
Adema, G ;
Adams, M ;
Ferrantini, M ;
Carpentier, AF ;
Escudier, B ;
Tursz, T ;
Angevin, E ;
Zitvogel, L .
JOURNAL OF IMMUNOLOGY, 2004, 172 (04) :2137-2146
[9]
Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes [J].
Chen, Shisheng ;
Lv, Mingfen ;
Fang, Shan ;
Ye, Wenxia ;
Gao, Yu ;
Xu, Yunsheng .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 113 :1182-1187
[10]
Exosomes secreted from human colorectal cancer cell lines contain mRNAs, microRNAs and natural antisense RNAs, that can transfer into the human hepatoma HepG2 and lung cancer A549 cell lines [J].
Chiba, Mitsuru ;
Kimura, Misako ;
Asari, Saya .
ONCOLOGY REPORTS, 2012, 28 (05) :1551-1558